-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $35

Benzinga·05/15/2026 12:20:05
Listen to the news
Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $25 to $35.